Macrolides and their role in the treatment of chronic rhinosinusitis

Rhinology and Facial Plastic Surgery

Volumn , Issue , 2009, Pages 295-305

  Cervin, Anders ^a,b   Wallwork, Ben ^c  

^a HELSINGBORG HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84857048521     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-74380-4_25     Document Type: Chapter

References (58)

1. McGuire JM, Bunch R, Anderson RC, Boaz HE, Flynn EH, Powell HM, et al.(1952) 'Ilotycin' an new antibiotic. Antibiot Chemother 2:281-283
2. Nagai H, Shishido H, Yoneda R, Yamaguchi E, Tamura A, Kurashima A (1991) Long-term low-dose administration of erythromycin to patients with difuse panbronchiolitis. Respiration 58:145-149
3. Kudoh S, Kimura H, Uetake T, et al.(1984) Clinical efect of low-dose, long-term macrolide antibiotic chemotherapy on difuse panbronchiolitis. Jpn J Torac Dis 22:254
4. Kikuchi S, Susaki H, Aoki A, Ito O, Nomura Y (1991) Clinical efect of long-term low-dose erythromycin therapy for chronic sinusitis (in Japanese with English abstract). Pract Otlo (Koyoto) 84:41-47
5. Stein GE, Havlichek DH (1992) Te new macrolide antibiotics. Azithromycin and clarithromycin. Postgrad Med 92:269-272, 77-82
6. Hirakata Y, Kaku M, Mizukane R, Ishida K, Furuya N, Matsu-moto T, et al.(1992) Potential efects of erythromycin on host defense systems and virulence of Pseudomonas aeruginosa. An-timicrob Agents Chemother 36:1922-1927
7. Sofer D, Gilboa-Garber N, Belz A, Garber NC (1999) 'Subinhibi-tory' erythromycin represses production of Pseudomonas aerug-inosa lectins, autoinducer and virulence factors. Chemotherapy 45:335-341
8. Wozniak DJ, Keyser R (2004) Efects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa. Chest 125(2 Suppl):62S-69S; quiz 9S
9. Takeoka K, Ichimiya T, Yamasaki T, Nasu M (1998) Te in vitro efect of macrolides on the interaction of human polymorpho-nuclear leukocytes with Pseudomonas aeruginosa in bioflm. Chemotherapy 44:190-197
10. Nalca Y, Jansch L, Bredenbruch F, Gefers R, Buer J, Haussler S (2006) Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach. Antimi-crob Agents Chemother 50:1680-1688
11. Stein G, Havlicheck DH (1992) Te new macrolide antibiotics: azithromycin and clarithromycin. Postgrad Med 92:269-282
12. Bermudez L, Inderlied C, Young LS (1991) Stimulation with cy-tokines enhances penetration of azithromycin into human macrophages. Antimicrob Agents Chemother 35:2625-2629
13. Lennard CM, Mann EA, Sun LL, Chang AS, Bolger WE (2000) Interleukin-1 beta, interleukin-5, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in chronic sinusitis: response to systemic corticosteroids. Am J Rhinol 14:367-373
14. Wallwork B, Coman W, Feron F, Mackay-Sim A, Cervin A (2002) Clarithromycin and prednisolone inhibit cytokine production in chronic rhinosinusitis. Laryngoscope 112:1827-1830
15. Suzuki H, Asada Y, Ikeda K, Furukawa M, Oshima T, Takasaka T (1999) Inhibitory efect of erythromycin on interleukin-8 secretion from exudative cells in the nasal discharge of patients with chronic sinusitis. Laryngoscope 109:407-410
16. Wallwork B, Coman W, Mackay-Sim A, Cervin A (2004) Efect of clarithromycin on nuclear factor-kappa B and transforming growth factor-beta in chronic rhinosinusitis. Laryngoscope 114:286-290
17. Inamura K, Ohta N, Fukase S, Kasajima N, Aoyagi M (2000) Te efect of erythromycin on human peripheral neutrophil apopto-sis. Rhinology 38:124-129
18. Aoshiba K, Nagai A, Konno K (1995) Erythromycin shortens neutrophil survival by accelerating apoptosis. Antimicrob Agents Chemother 39:872-877
19. Hand W, Hand D, King-Tompson N (1990) Antibiotic inhibition of the respiratory burst response in human polymorphonu-clear leukocytes. Antimicrob Agents Chemother 34:863-870
20. Braga P, Maci S, Dal Sasso M, Fonti E, Ghessi A (1997) Efects of rokitamycin on phagocytosis and release of oxidant radicals of human polymorphonuclear leukocytes. Chemotherapy 43:190-197
21. Lin H, Wang C, Liu C, Yu C, Kuo H (2000) Erythromycin inhibits beta2-integrins (CD11b/CD18) expression, interleukin-8 release and intracellular oxidative metabolism in neutrophils. Respir Med 94:654-660
22. Matsuoka N, Eguchi K, Kawakami A, Tsuboi M, Kawabe Y, Aoy-agi T, Nagataki S (1996) Inhibitory efect of clarithromycin on costimulatory molecule expression and cytokine production by synovial fbroblast-like cells. Clin Exp Immunol 104:501-508
23. Baeuerle P, Henkel T (1994) Function and activation of NF-kap-paB in the immune system. Annu Rev Immunol 12:141-179
24. Miyanohara T, Ushikai M, Matsune S, Ueno K, Katahira S, Kurono Y (2000) Efects of clarithromycin on cultured human nasal epithelial cells and fbroblasts. Laryngoscope 110:126-131
25. Desaki M, Takizawa H, Ohtoshi T, Kasama T, Kobayashi K, Su-nazuka T, Omura S, Yamamoto K, Ito K (2000) Erythromycin suppresses nuclear factor kappa-B and activator protein-1 activation in human bronchial epithelial cells. Biochem Biophys Res Commun 267:124-128
26. Nakano T, Ohashi Y, Tanaka A, Kakinoki Y, Washio Y, Nakai Y (1998) Roxithromycin reinforces epithelial defence function in rabbit trachea. Acta Otolaryngol Suppl 538:233-238
27. Tamaoki J, Takeyama K, Yamawaki I, Kondo M, Konno K (1997) Lipopolysaccharide-induced goblet cell hypersecretion in the guinea pig trachea: inhibition by macrolides. Am J Physiol 272:15-19
28. Rhee C, Majima Y, Arima S, Jung H, Jinn T, Min Y, Sakakura Y (2000) Efects of clarithromycin on rheological properties of nasal mucous in patients with chronic sinusitis. Ann Otol Rhinol Laryngol 109:484-487
29. Rubin B, Druce H, Ramirez OE, Palmer R (1997) Efect of clarithromycin on nasal mucus properties in healthy subjects and in patients with purulent rhinitis. Am J Respir Crit Care Med 155:2018-2023
30. Nishi K, Mizuguchi M, Tachibana H, et al.(1995) Efect of clarithromycin on symptoms and mucociliary transport in patients with sino-bronchial syndrome. Nippon Shikkan Gakkai Zasshi 33:1392-1400
31. Wallwork B, Coman W, Mackay-Sim A, Greif L, Cervin A (2006) A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope 116:189-193
32. Kudoh S, Azuma A, Yamamoto M, Izumi T, Ando M (1998) Improvement of survival in patients with difuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 157:1829-1832
33. Pukhalsky AL, Shmarina GV, Kapranov NI, Kokarovtseva SN, Pukhalskaya D, Kashirskaja NJ (2004) Anti-infammatory and immunomodulating efects of clarithromycin in patients with cystic fbrosis lung disease. Mediators Infamm 13:111-117
34. Equi A, Balfour-Lynn IM, Bush A, Rosenthal M (2002) Long term azithromycin in children with cystic fbrosis: a randomised, placebo-controlled crossover trial. Lancet 360:978-984
35. Equi AC, Davies JC, Painter H, Hyde S, Bush A, Geddes DM, et al.(2006) Exploring the mechanisms of macrolides in cystic fbrosis. Respir Med 100:687-697
36. Saiman L, Mayer-Hamblett N, Campbell P, Marshall BC (2005) Heterogeneity of treatment response to azithromycin in patients with cystic fbrosis. Am J Respir Crit Care Med 172:1008-1012
37. Saiman L, Marshall BC, Mayer-Hamblett N, Burns JL, Quittner AL, Cibene DA, et al.(2003) Azithromycin in patients with cystic fbrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 290:1749-1756
38. Wolter J, Seeney S, Bell S, Bowler S, Masel P, McCormack J (2002) Efect of long term treatment with azithromycin on disease parameters in cystic fbrosis: a randomised trial. Torax 57:212-216
39. Black PN, Blasi F, Jenkins CR, Scicchitano R, Mills GD, Rubinfeld AR, et al.(2001) Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumo-niae. Am J Respir Crit Care Med 164:536-541
40. Kostadima E, Tsiodras S, Alexopoulos EI, Kaditis AG, Mavrou I, Georgatou N, et al.(2004) Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma. Eur Respir J 23:714-717
41. Kraf M, Cassell GH, Pak J, Martin RJ (2002) Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: efect of clarithromycin. Chest 121:1782-1788
42. Shoji T, Yoshida S, Sakamoto H, Hasegawa H, Nakagawa H, Amayasu H (1999) Anti-infammatory efect of roxithromycin in patients with aspirin-intolerant asthma. Clin Exp Allergy 29:950-956
43. Banerjee D, Khair OA, Honeybourne D (2005) Te efect of oral clarithromycin on health status and sputum bacteriology in stable COPD. Respir Med 99:208-215
44. Banerjee D, Honeybourne D, Khair OA (2004) Te efect of oral clarithromycin on bronchial airway infammation in moderate-to-severe stable COPD: a randomized controlled trial. Treat Re-spir Med 3:59-65
45. Koh YY, Lee MH, Sun YH, Sung K W, Chae JH (1997) Efect of roxithromycin on airway responsiveness in children with bron-chiectasis: a double-blind, placebo-controlled study. Eur Respir J 10:994-999
46. Nakamura H, Fujishima S, Inoue T, Ohkubo Y, Soejima K, Waki Y, et al.(1999) Clinical and immunoregulatory efects of rox-ithromycin therapy for chronic respiratory tract infection. Eur Respir J 13:1371-1379
47. MacLeod CM, Hamid QA, Cameron L, Tremblay C, Brisco W (2001) Anti-infammatory activity of clarithromycin in adults with chronically infamed sinus mucosa. Adv Ter 18:75-82
48. Suzuki H, Shimomura A, Ikeda K, Oshima T, Takasaka T (1997) Efects of long-term low-dose macrolide administration on neu-trophil recruitment and IL-8 in the nasal discharge of chronic sinusitis patients. Tohoku J Exp Med 182:115-124
49. Yamada T, Fujieda S, Mori S, Yamamoto H, Saito H (2000) Mac-rolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage. Am J Rhinol 14:143-148
50. Rhee CS, Majima Y, Arima S, Jung HW, Jinn TH, Min YG, et al. (2000) Efects of clarithromycin on rheological properties of nasal mucus in patients with chronic sinusitis. Ann Otol Rhinol Laryngol 109:484-487
51. Ichimura K, Shimazaki Y, Ishibashi T, Higo R (1996) Efect of new macrolide roxithromycin upon nasal polyps associated with chronic sinusitis. Auris Nasus Larynx 23:48-56
52. Hashiba M, Baba S (1996) Efcacy of long-term administration of clarithromycin in the treatment of intractable chronic sinusitis. Acta Otolaryngol Suppl (Stockh) 525:73-78
53. Cervin A, Kalm O, Sandkull P, Lindberg S (2002) One-year low-dose erythromycin treatment of persistent chronic sinusitis afer sinus surgery: clinical outcome and efects on mucociliary parameters and nasal nitric oxide. Otolaryngol Head Neck Surg 126:481-489
54. Ragab SM, Lund VJ, Scadding G (2004) Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial. Laryngoscope 114:923-930
55. Moriyama H, Yanagi K, Ohtori N, Fukami M (1995) Evaluation of endoscopic sinus surgery for chronic sinusitis: post-operative erythromycin therapy. Rhinology 33:166-170
56. Suzuki H, Ikeda K, Honma R, Gotoh S, Oshima T, Furukawa M, et al.(2000) Prognostic factors of chronic rhinosinusitis under long-term low-dose macrolide therapy. ORL J Otorhinolaryngol Relat Spec 62:121-127
57. Kimura N, Nishioka K, Nishizaki K, Ogawa T, Naitou Y, Masuda Y (1997) Clinical efect of low-dose, long-term roxithromy-cin chemotherapy in patients with chronic sinusitis. Acta Med Okayama 51:33-37
58. Iino Y, Sugita K, Toriyama M, Kudo K (1993) Erythromycin therapy for otitis media with efusion in sinobronchial syndrome. Arch Otolaryngol Head Neck Surg 119:648-651